Chloroform fraction of Scutellaria barbata D. Don inhibits the growth of colorectal cancer cells by activating miR‑34a

Oncology Reports
Ling ZhangJun Peng

Abstract

Scutellaria barbata D. Don (SB) is a well known formula in traditional Chinese medicine, which exhibits potent anticancer effects on various cancers. Many miRNAs play crucial roles in the regulation of cancer, for instance, miR‑34a functions as a tumor suppressor, and is often downregulated during cancer. In this study, we investigated the role of ECSB in suppressing the growth of human colon cancer HCT‑8 cells, and whether this is mediated by regulation of miR‑34a and its downstream target genes, using real-time PCR and western blot analysis. ECSB treatment significantly inhibited the proliferation of HCT‑8 cells and promoted apoptosis in a dose-dependent manner. In addition, ECSB treatment significantly increased the level of miR‑34a expression and decreased the levels of Bcl-2, Notch1/2 and Jagged1 expression. Furthermore, knockdown of miR‑34a expression through transfection of anti-miR‑34a oligonucleotide was significantly reversed by ECSB treatment. Likewise, knockdown of miR‑34a resulted in significant upregulation of Bcl-2, Notch1/2 and Jagged1 expression, which was reversed following ECSB treatment. Therefore, this study reveals that ECSB inhibited cancer cell growth via promoting apoptosis and inhibiting proliferation,...Continue Reading

References

Mar 25, 2006·Nature Reviews. Cancer·Aurora Esquela-Kerscher, Frank J Slack
Oct 25, 2006·Nature Reviews. Cancer·George A Calin, Carlo M Croce
Jun 2, 2007·Molecular Cell·Nina Raver-ShapiraMoshe Oren
Aug 23, 2008·Cell Cycle·Dmitri LodyginHeiko Hermeking
May 23, 2009·Cell Death and Differentiation·H Hermeking
Sep 24, 2009·Cancer Research·Yunqing LiRoger Abounader
Feb 22, 2012·Journal of Ethnopharmacology·Alessandro BurianiPeter J Hylands
Nov 7, 2012·Journal of Cellular Biochemistry·Feng GaoHuijun Duan
Nov 14, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Jie GaoWang-Gang Zhang
Mar 19, 2014·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Feb 6, 2015·CA: a Cancer Journal for Clinicians·Lindsey A TorreAhmedin Jemal
Nov 1, 2014·Thoracic Cancer·Huajiao GuoJian Zhang
Mar 12, 2016·Journal of Experimental & Clinical Cancer Research : CR·Yudan Chi, Dongming Zhou
May 14, 2016·Journal of the Royal Society, Interface·Marcelo BoaretoJose' N Onuchic

❮ Previous
Next ❯

Citations

Jun 10, 2021·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Wenjun Li, Hongxia Xiao
Jul 20, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Samira EghbaliFerizZahra Tayarani-Najaran

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.